Skip to content

Volume 128 · 2127

Public Law 113–233

To expand the program of priority review to encourage treatments for tropical diseases.

Approved December 16, 2014

Statutory text

An Act

To expand the program of priority review to encourage treatments for tropical diseases.

Dec. 16, 2014

[S. 2917]

Be it enacted by the Senate and House of Representa­tives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

  This Act may be cited as the “Adding Ebola to the FDA Priority Review Voucher Program Act”.

SEC. 2. PRIORITY REVIEW TO ENCOURAGE TREATMENTS FOR TROPICAL DISEASES.

  Section 524 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended—

(1)

in subsection (a)(3)—

(A)

by redesignating subparagraph (Q) as subparagraph (R);

(B)

by inserting after subparagraph (P) the following:

“(Q)

Filoviruses.”

; and

(C)

in subparagraph (R), as so redesignated, by striking “regulation by” and inserting “order of”; and

(2)

in subsection (b)—

(A)

in paragraph (2), by adding “There is no limit on the number of times a priority review voucher may be transferred before such voucher is used.” after the period at the end; and

(B)

in paragraph (4), by striking “365 days” and inserting “90 days”.

Approved .

Parsed from the official Statutes at Large USLM XML in 128.xml